Simplex Trading’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $11.7M | Sell |
23,300
-1,200
| -5% | -$634K | 0.01% | 675 |
|
|
2026
Q2 | $13.2M | Sell |
24,500
-4,700
| -16% | -$2.41M | 0.01% | 628 |
|
|
2026
Q1 | $15.3M | Buy |
+29,200
| New | +$14M | 0.01% | 520 |
|
|
2025
Q4 | – | Sell |
-23,200
| Closed | -$10.6M | – | 9435 |
|
|
2025
Q3 | $10.6M | Buy |
23,200
+8,500
| +58% | +$3.17M | 0.01% | 927 |
|
|
2025
Q2 | $4.45M | Sell |
14,700
-900
| -6% | -$268K | ﹤0.01% | 1446 |
|
|
2025
Q1 | $5.17M | Sell |
15,600
-18,500
| -54% | -$6.08M | ﹤0.01% | 1285 |
|
|
2024
Q4 | $10.5M | Buy |
34,100
+6,400
| +23% | +$1.8M | 0.01% | 1001 |
|
|
2024
Q3 | $5.88M | Sell |
27,700
-11,700
| -30% | -$2.99M | ﹤0.01% | 1383 |
|
|
2024
Q2 | $11M | Sell |
39,400
-32,800
| -45% | -$7.81M | 0.01% | 952 |
|
|
2024
Q1 | $19.3M | Buy |
72,200
+21,600
| +43% | +$5.09M | 0.01% | 717 |
|
|
2023
Q4 | $11.7M | Buy |
50,600
+800
| +2% | +$140K | 0.01% | 986 |
|
|
2023
Q3 | $7.27M | Buy |
49,800
+11,200
| +29% | +$2.11M | 0.01% | 1104 |
|
|
2023
Q2 | $8.92M | Sell |
38,600
-4,000
| -9% | -$1.08M | 0.01% | 957 |
|
|
2023
Q1 | $10.3M | Sell |
42,600
-6,800
| -14% | -$1.85M | 0.01% | 885 |
|
|
2022
Q4 | $14.3M | Buy |
49,400
+23,400
| +90% | +$2.29M | 0.02% | 696 |
|
|
2022
Q3 | $1.69M | Buy |
26,000
+21,300
| +453% | +$1.48M | ﹤0.01% | 2108 |
|
|
2022
Q2 | $336K | Buy |
4,700
+3,500
| +292% | +$257K | ﹤0.01% | 3951 |
|
|
2022
Q1 | $117K | Sell |
1,200
-7,100
| -86% | -$599K | ﹤0.01% | 5927 |
|
|
2021
Q4 | $703K | Buy |
8,300
+5,700
| +219% | +$468K | ﹤0.01% | 3356 |
|
|
2021
Q3 | $258K | Hold |
2,600
| – | – | ﹤0.01% | 5169 |
|
|
2021
Q2 | $253K | Buy |
2,600
+2,581
| +13,584% | +$306K | ﹤0.01% | 5285 |
|
|
2021
Q1 | $222K | Sell |
19
-116
| -86% | -$13.5K | ﹤0.01% | 4594 |
|
|
2020
Q4 | $1.5M | Buy |
135
+64
| +90% | +$7.82K | ﹤0.01% | 2068 |
|
|
2020
Q3 | $842K | Buy |
71
+56
| +373% | +$6.08K | ﹤0.01% | 2425 |
|
|
2020
Q2 | $169K | Buy |
15
+4
| +36% | +$393 | ﹤0.01% | 4183 |
|
|
2020
Q1 | $73K | Sell |
11
-6
| -35% | -$500 | ﹤0.01% | 4719 |
|
|
2019
Q4 | $154K | Sell |
17
-4
| -19% | -$388 | ﹤0.01% | 4032 |
|
|
2019
Q3 | $181K | Buy |
21
+4
| +24% | +$375 | ﹤0.01% | 3669 |
|
|
2019
Q2 | $178K | Sell |
17
-80
| -82% | -$8.57K | ﹤0.01% | 3584 |
|
|
2019
Q1 | $1.22M | Buy |
97
+17
| +21% | +$2.11K | ﹤0.01% | 1824 |
|
|
2018
Q4 | $901K | Buy |
80
+23
| +40% | +$3.56K | ﹤0.01% | 1711 |
|
|
2018
Q3 | $1.22M | Buy |
+57
| New | +$14.3K | ﹤0.01% | 1693 |
|
Other funds holding MDGL
Simplex Trading's MDGL Position: Q3 2026 in Review
Simplex Trading opened a new position in Madrigal Pharmaceuticals (MDGL) in Q3 2026: 3,751 shares worth $1.89M. The stake represents ﹤0.01% of the portfolio and ranks #2054 among its holdings. This is a return to the name: Simplex Trading previously reported a position in MDGL as recently as Q3 2024.
Simplex Trading first reported a position in MDGL in Q4 2014 and has held it in 29 quarters since. The position peaked at $5.23M in Q2 2023. 226 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.
- Simplex Trading held 3,751 shares of Madrigal Pharmaceuticals worth $1.89M as of Q3 2026.
- Madrigal Pharmaceuticals was a new Simplex Trading position in Q3 2026.
- Madrigal Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #2054 holding.
- Simplex Trading first reported a position in Madrigal Pharmaceuticals in Q4 2014 and has held it in 29 quarters since.
- Simplex Trading's Madrigal Pharmaceuticals position peaked at $5.23M in Q2 2023.
- 226 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.
Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.